An Interview with Ian Holloway, MHRA: A Regulatory Response to New Temperature Monitoring Technologies
Add bookmark
"We are seeing now a lot of new technologies and service providers for the cold chain which has great benefits for companies to adopt. If they bring these in-house they can increase standards and increasingly the regulators are expecting companies to do this and to invest in improving their own systems," Ian Holloway, Manager, Defective Medicines Reporting Centre, MHRA, shares his insights with Pharma IQ, at IQPC's 10th Annual Cool Chain Europe 2011. Watch now for more... [inlinead]
